Hormonal response to dehydroepiandrosterone administration in schizophrenia: Findings from a randomized, double-blind, placebo-controlled, crossover study

Journal of Clinical Psychopharmacology

Volumn 28, Issue 4, 2008, Pages 456-459

  Strous, Rael David ^a,b   Gibel, Anatoly ^c   Maayan, Rachel ^b   Weizman, Abraham ^b,d   Ritsner, Michael S ^b,e  

^a BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

^d GEHA MENTAL HEALTH CENTER   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANDROSTENEDIONE; ESTRADIOL; HYDROCORTISONE; INSULIN; NEUROSTEROID; PRASTERONE; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE; THYROTROPIN; CORTICOSTEROID; HORMONE; NEUROLEPTIC AGENT;

ADULT; ATTENTION; CLINICAL TRIAL; COGNITION; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; NERVE CELL EXCITABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; SYMPTOMATOLOGY; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADRENAL CORTEX HORMONES; ADULT; ANTIPSYCHOTIC AGENTS; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HORMONES; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEX FACTORS;

EID: 54449100247     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31817d86de     Document Type: Letter

References (14)

1. Kroboth PD, Salek FS, Pittenger AL, et al. DHEA and DHEA-S: a review. J Clin Pharmacol. 1999;39:327-348.
2. Rupprecht R, di Michele F, Hermann B, et al. Neuroactive steroids: molecular mechanisms of action and implications for neuropsy- chopharmacology. Brain Res Rev. 2001;37:59-67.
3. Baulieu EE, Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuro- active neurosteroids. J Endocrinol. 1996;150 Suppl:S221-239.
4. Strous RD, Maayan R, Lapidus R, et al. Value of dehydroepiandrosterone (DHEA) augmentation in the management of negative, depressive and anxiety symptoms in schizophrenia. Arch Gen Psych. 2003;60:133-141.
5. Strous RD, MaayanR,KotlerM,etal. Hormonal profile effects following dehydroe- piandrosterone (DHEA) administration to schizophrenic patients. Clin Neuropharmacol. 2005;28:265-269.
6. Nachshoni T, Ebert T, Abramovitch Y, et al. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial. Schizophr Res. 2005;79:251-256.
7. Strous RD, Stryjer R, Maayan R, et al. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, doubleblind placebo controlled trial. Psychoneuroen-docrinology. 2007;32:96-105.
8. Ritsner MS, Gibel A, Ratner Y, et al. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, doubleblind, placebo-controlled, crossover trial. J Clin Psychopharmacol. 2006;26:495-499.
9. Tourney G, Hatfield L. Plasma androgens in male schizophrenics. Arch Gen Psychiatry. 1972;27:753-755.
10. Ritsner M, Gibel A, Maayan R, et al. Cortisol/ dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia. Neuropsychopharmacology. 2005;30: 1913-1922.
11. Ritsner M, Gibel A, Ram E, et al. Alterations in DHEA metabolism in schizophrenia: two- month case-control study. Eur Neuropsycho-pharmacol. 2006;16:137-146.
12. Ritsner M, Gibel A, Maayan R, et al. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients. Eur Neuro- psychopharmacol. 2007;17:257-264.
13. Andrade S, Silveira SL, Gomez R, et al. Gender differences of acute and chronic administration of dehydroepiandrosterone in rats submitted to the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:613-621.
14. Bernardi F, Casarosa E, Pluchino N, et al. Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin. Fertil Steril. 2005;83 Suppl 1:1161-1168.